Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

Jeanne Whalen writes about the U.S. economy from the Chicago bureau. She previously covered healthcare, general news and ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

Clinical-stage company targeting fundamental drivers of inflammation, autoimmunity and fibrosis, founded by Versant Ventures and Novartis Venture Fund- ...

GSK plc, formerly known as GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company headquartered in London. Established in 2000 through the merger of Glaxo ...

April 17, 2025--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted ... now part of GlaxoSmithKline plc, where he spent 10 years in a range ...

The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, Bristol Myers Squibb, and AstraZeneca. As North ...

Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...

Eli Lilly and Company received FDA approval for selpercatinib ... companies such as Mylan Pharmaceuticals Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and many others ...